These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 36476380)

  • 21. Recurrent SARS-CoV-2 spike mutations confer growth advantages to select JN.1 sublineages.
    Wang Q; Mellis IA; Ho J; Bowen A; Kowalski-Dobson T; Valdez R; Katsamba PS; Wu M; Lee C; Shapiro L; Gordon A; Guo Y; Ho DD; Liu L
    Emerg Microbes Infect; 2024 Dec; 13(1):2402880. PubMed ID: 39259045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotyping the virulence of SARS-CoV-2 variants in hamsters by digital pathology and machine learning.
    Meehan GR; Herder V; Allan J; Huang X; Kerr K; Mendonca DC; Ilia G; Wright DW; Nomikou K; Gu Q; Molina Arias S; Hansmann F; Hardas A; Attipa C; De Lorenzo G; Cowton V; Upfold N; Palmalux N; Brown JC; Barclay WS; Filipe ADS; Furnon W; Patel AH; Palmarini M
    PLoS Pathog; 2023 Nov; 19(11):e1011589. PubMed ID: 37934791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated all-atom and coarse-grained simulations uncover structural, dynamics and energetic shifts in SARS-CoV-2 JN.1 and BA.2.86 variants.
    Sharma A; Maurya S; Tripathi T; Padhi AK
    Acta Trop; 2024 Dec; 260():107444. PubMed ID: 39471972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re-Evaluation and Retrospective Comparison of Serum Neutralization Induced by Three Different Types of Inactivated SARS-CoV-2 Vaccines.
    Jiang W; Wu J; He J; Xia A; Wu W; Gao Y; Zhang Q; Peng X; Jiang Q; Xue S; Wang Q
    Vaccines (Basel); 2024 Oct; 12(11):. PubMed ID: 39591107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants.
    Changrob S; Halfmann PJ; Liu H; Torres JL; McGrath JJC; Ozorowski G; Li L; Wilbanks GD; Kuroda M; Maemura T; Huang M; Zheng NY; Turner HL; Erickson SA; Fu Y; Yasuhara A; Singh G; Monahan B; Mauldin J; Srivastava K; Simon V; Krammer F; Sather DN; Ward AB; Wilson IA; Kawaoka Y; Wilson PC
    J Clin Invest; 2023 Apr; 133(8):. PubMed ID: 36862518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring distinct modes of inter-spike cross-linking for enhanced neutralization by SARS-CoV-2 antibodies.
    Nan X; Li Y; Zhang R; Wang R; Lv N; Li J; Chen Y; Zhou B; Wang Y; Wang Z; Zhu J; Chen J; Li J; Chen W; Zhang Q; Shi X; Zhao C; Chen C; Liu Z; Zhao Y; Liu D; Wang X; Yan LT; Li T; Zhang L; Yang YR
    Nat Commun; 2024 Dec; 15(1):10578. PubMed ID: 39632831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters.
    Halfmann PJ; Iwatsuki-Horimoto K; Kuroda M; Hirata Y; Yamayoshi S; Iida S; Uraki R; Ito M; Ueki H; Furusawa Y; Sakai-Tagawa Y; Kiso M; Armbrust T; Spyra S; Maeda K; Wang Z; Imai M; Suzuki T; Kawaoka Y
    Commun Biol; 2024 Mar; 7(1):331. PubMed ID: 38491227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization.
    Cele S; Jackson L; Khoury DS; Khan K; Moyo-Gwete T; Tegally H; San JE; Cromer D; Scheepers C; Amoako DG; Karim F; Bernstein M; Lustig G; Archary D; Smith M; Ganga Y; Jule Z; Reedoy K; Hwa SH; Giandhari J; Blackburn JM; Gosnell BI; Abdool Karim SS; Hanekom W; ; ; von Gottberg A; Bhiman JN; Lessells RJ; Moosa MS; Davenport MP; de Oliveira T; Moore PL; Sigal A
    Nature; 2022 Feb; 602(7898):654-656. PubMed ID: 35016196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omicron infection enhances Delta antibody immunity in vaccinated persons.
    Khan K; Karim F; Cele S; Reedoy K; San JE; Lustig G; Tegally H; Rosenberg Y; Bernstein M; Jule Z; Ganga Y; Ngcobo N; Mazibuko M; Mthabela N; Mhlane Z; Mbatha N; Miya Y; Giandhari J; Ramphal Y; Naidoo T; Sivro A; Samsunder N; Kharsany ABM; Amoako D; Bhiman JN; Manickchund N; Abdool Karim Q; Magula N; Abdool Karim SS; Gray G; Hanekom W; von Gottberg A; ; Milo R; Gosnell BI; Lessells RJ; Moore PL; de Oliveira T; Moosa MS; Sigal A
    Nature; 2022 Jul; 607(7918):356-359. PubMed ID: 35523247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omicron breakthrough infections in vaccinated or previously infected hamsters.
    Zhou J; Sukhova K; Peacock TP; McKay PF; Brown JC; Frise R; Baillon L; Moshe M; Kugathasan R; Shattock RJ; Barclay WS
    Proc Natl Acad Sci U S A; 2023 Nov; 120(45):e2308655120. PubMed ID: 37903249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid spread of the SARS-CoV-2 Omicron XDR lineage derived from recombination between XBB and BA.2.86 subvariants circulating in Brazil in late 2023.
    Arantes I; Ito K; Gomes M; Carvalho FCd; Ferreira de Almeida WA; Khouri R; Miyajima F; Wallau GL; Naveca FG; Pereira EC; ; Mendonça Siqueira M; Resende PC; Bello G
    Microbiol Spectr; 2024 Nov; ():e0119324. PubMed ID: 39611827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 correlates of protection from infection against variants of concern.
    Sun K; Bhiman JN; Tempia S; Kleynhans J; Madzorera VS; Mkhize Q; Kaldine H; McMorrow ML; Wolter N; Moyes J; Carrim M; Martinson NA; Kahn K; Lebina L; du Toit JD; Mkhencele T; von Gottberg A; Viboud C; Moore PL; Cohen C;
    Nat Med; 2024 Oct; 30(10):2805-2812. PubMed ID: 39060660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host immune responses associated with SARS-CoV-2 Omicron infection result in protection or pathology during reinfection depending on mouse genetic background.
    Singh G; Warang P; García-Bernalt Diego J; Chang L; Bykov Y; Singh S; Pache L; Cuadrado-Castano S; Webb B; Garcia-Sastre A; Schotsaert M
    Res Sq; 2023 Nov; ():. PubMed ID: 38077015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants.
    Reuschl AK; Thorne LG; Whelan MVX; Ragazzini R; Furnon W; Cowton VM; De Lorenzo G; Mesner D; Turner JLE; Dowgier G; Bogoda N; Bonfanti P; Palmarini M; Patel AH; Jolly C; Towers GJ
    Nat Microbiol; 2024 Feb; 9(2):451-463. PubMed ID: 38228858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic evolution: The dynamic adaptation of SARS-CoV-2 and human protective immunity in the real world.
    Li Y; Zhang X; Yi J; Chen Y; Liang J; Wang L; Ma J; Zhu R; Zhang X; Hu D; Jia Y; Yu X; Wang Y
    J Infect; 2024 Dec; 89(6):106310. PubMed ID: 39393556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural insight into broadening SARS-CoV-2 neutralization by an antibody cocktail harbouring both NTD and RBD potent antibodies.
    Jiang W; Jiang Y; Sun H; Deng T; Yu K; Fang Q; Ge H; Lan M; Lin Y; Fang Z; Zhang Y; Zhou L; Li T; Yu H; Zheng Q; Li S; Xia N; Gu Y
    Emerg Microbes Infect; 2024 Dec; 13(1):2406300. PubMed ID: 39470577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity.
    Khatri R; Siddqui G; Sadhu S; Maithil V; Vishwakarma P; Lohiya B; Goswami A; Ahmed S; Awasthi A; Samal S
    Med Microbiol Immunol; 2023 Feb; 212(1):103-122. PubMed ID: 36583790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination.
    Wang M; Zhang L; Li Q; Wang B; Liang Z; Sun Y; Nie J; Wu J; Su X; Qu X; Li Y; Wang Y; Huang W
    Emerg Microbes Infect; 2022 Dec; 11(1):18-29. PubMed ID: 34818119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemic.
    Akerman A; Fichter C; Milogiannakis V; Esneau C; Silva MR; Ison T; Lopez JA; Naing Z; Caguicla J; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Boss T; Condylios A; Yeang M; Sato K; Bartlett NN; Darley D; Matthews G; Stark DJ; Promsri S; Rawlinson WD; Murrell B; Kelleher AD; Dwyer D; Sintchenko V; Kok J; Ellis S; Marris K; Knight E; Hoad VC; Irving DO; Gosbell I; Brilot F; Wood J; Aggarwal A; Turville SG
    EBioMedicine; 2024 Dec; 110():105415. PubMed ID: 39549677
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.